BIOCON:NSE
Biocon Ltd
₹352.00
arrow_upward
+0.40%(+1.40) 1 日
10月15日, 15:30:00 GMT+5:30 · INR
search
すべての記号
| 記号 | 価格 | 変化 | 変化率 |
|---|
insights_autoBIOCON の上位の分析情報を生成しています...
始値
₹354.00
高値
₹356.35
安値
₹350.00
時価総額
4211.85億
平均出来高
309.97万
取引量
173.18万
配当
0.14%
四半期配当
₹0.12
配当落ち日
2026/07/03
株価収益率
104.21
52 週高値
₹447.15
52 週安値
₹337.70
EPS
₹3.38
発行済株式数
6.00億
従業員数
2万
始値
₹354.00
高値
₹356.35
安値
₹350.00
時価総額
4211.85億
平均出来高
309.97万
取引量
173.18万
配当
0.14%
四半期配当
₹0.12
配当落ち日
2026/07/03
株価収益率
104.21
52 週高値
₹447.15
52 週安値
₹337.70
EPS
₹3.38
発行済株式数
6.00億
従業員数
2万
ニュース記事
情報源: ウェブソース、ニュース パートナー
プロフィール
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics, and branded drugs such as biosimilar insulins and antibodies for the Indian domestic market. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
Biocon Ltd について